Format

Send to

Choose Destination
Adv Exp Med Biol. 2017;967:315-323. doi: 10.1007/978-3-319-63245-2_19.

Redox Signaling in the Right Ventricle.

Author information

1
Department of Pharmacology and Physiology, Georgetown University Medical Center, 3900 Reservoir Road NW, Washington, DC, 20057, USA. ys82@georgetown.edu.
2
Department of Pharmacology and Physiology, Georgetown University Medical Center, 3900 Reservoir Road NW, Washington, DC, 20057, USA.

Abstract

Pulmonary hypertension is a devastating disease without cure. The major cause of death among patients with pulmonary hypertension is right heart failure; however, biology of the right heart is not well understood. This lack of knowledge interferes with developing effective therapeutic strategies to treat these patients. In this chapter, we summarize studies performed in our laboratory that investigated the role of redox signaling in the regulation of the right ventricle (RV), using rat models of experimental pulmonary hypertension and right heart failure. Specifically, this chapter covers the topics of (a) redox regulation of serotonin signaling in the RV, (b) the carbonylation-degradation pathway of signal transduction in RV hypertrophy and (c) oxidative modifications in the RV of the SU5416/ovalbumin model of pulmonary arterial hypertension. These studies revealed that redox regulation in the RV is complex and simply giving lots of antioxidants to patients will unlikely benefit them. Deeper understanding of specific and selective redox mechanisms should shed light on how we can develop therapeutic strategies by modulating redox reactions.

KEYWORDS:

Annexin A1; CBF/NF-Y; GATA4; Hypoxia; Monoamine Oxidase A; Pulmonary Hypertension; Reactive Oxygen Species; Right Ventricular Hypertrophy; Serotonin

PMID:
29047095
DOI:
10.1007/978-3-319-63245-2_19
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center